Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.

about

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.

P2860

Q38849814-6185EBE5-549F-447A-A1B3-A09E56F8628E

P2860

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.

Item

http://www.wikidata.org/entity/Q38853002

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Second-line HIV Treatment in U ...... Protease Inhibitor Resistance.

@en

type

Item

label

Second-line HIV Treatment in U ...... Protease Inhibitor Resistance.

@en

prefLabel

Second-line HIV Treatment in U ...... Protease Inhibitor Resistance.

@en

P1476

Second-line HIV Treatment in U ...... Protease Inhibitor Resistance.

@en

P2093

Andrew Mukuye

http://www.w3.org/2001/XMLSchema#string

Cissy Kityo

http://www.w3.org/2001/XMLSchema#string

Elizabeth Kaudha

http://www.w3.org/2001/XMLSchema#string

Immaculate Nankya

http://www.w3.org/2001/XMLSchema#string

Job C J Calis

http://www.w3.org/2001/XMLSchema#string

Joshua Kayiwa

http://www.w3.org/2001/XMLSchema#string

Kim C E Sigaloff

http://www.w3.org/2001/XMLSchema#string

Lilian Nakatudde

http://www.w3.org/2001/XMLSchema#string

Mary Kiconco

http://www.w3.org/2001/XMLSchema#string

Michael Boele van Hensbroek

http://www.w3.org/2001/XMLSchema#string

P2860

Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.

Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers' report

Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Carbohydrate malabsorption in acutely malnourished children and infants: a systematic review.

Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy.

Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy.

Web resources for HIV type 1 genotypic-resistance test interpretation.

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda

P304

135-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/TROPEJ/FMW062

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Victor Musiime

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27634175

http://www.w3.org/2001/XMLSchema#string

P921

Uganda

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.

about

P2860

P2860

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921